DR. RICHARD DAIFUKU, MD
Medical Practice at 36 Pl, Mercer Island, WA
License number
Washington MD00032649
Category
Medical Practice
Type
Research Study
Address
Address
9270 SE 36Th Pl, Mercer Island, WA 98040
Phone
(206) 232-0061
Organization information
See more information about RICHARD DAIFUKU at bizstanding.comRichard Daifuku MD
9270 SE 36 Pl, Mercer Island, WA 98040
Industry:
Internist
Phone:
(206) 521-7881 (Phone)
Richard Daifuku
Richard Daifuku Consulting Inc
9270 SE 36 Pl, Mercer Island, WA 98040
Status:
Inactive
Industry:
Business Consulting Services
Phone:
(206) 232-0061 (Phone)
Medical Doctor, Owner:
Richard Daifuku (Medical Doctor, Owner)
Categories:
Management Consultants
Professional information
Mutagenic Nucleoside Analogs For The Treatment Of Viral Disease
US Patent:
7648967, Jan 19, 2010
Filed:
Feb 13, 2006
Appl. No.:
11/353489
Inventors:
Ling Li - Seattle WA, US
Alexander Gall - Woodinville WA, US
Richard Daifuku - Mercer Island WA, US
Alexander Gall - Woodinville WA, US
Richard Daifuku - Mercer Island WA, US
Assignee:
Koronis Pharmaceuticals, Incorporated - Redmond WA
International Classification:
A61K 31/70, C07H 19/167, C07H 19/173, C07H 19/20, C12P 19/40, C12P 19/30, C12P 19/34
US Classification:
514 45, 514 48, 435 88, 435 89, 435 9121, 536 2626, 536 267, 536 277
Abstract:
The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs. In particular, the invention provides isoguanosine nucleosides and derivatives thereof as well a method of increasing the mutation rate of a virus such as bovine viral diarrhea virus (BVDV) and hepatitis C virus (HCV).
1,3,5-Triazines For Treatment Of Viral Diseases
US Patent:
7642247, Jan 5, 2010
Filed:
Feb 6, 2007
Appl. No.:
11/671964
Inventors:
Richard Daifuku - Mercer Island WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Assignee:
Koronis Pharmaceuticals, Incorporated - Redmond WA
International Classification:
A61K 31/706, A61K 31/7068, C07H 19/12
US Classification:
514 43, 514 53, 536 283
Abstract:
The present invention provides compounds and methods for treatment of viral diseases and cancer.
Prodrugs Of Heteroaryl Compounds
US Patent:
7982034, Jul 19, 2011
Filed:
Apr 7, 2009
Appl. No.:
12/419959
Inventors:
Richard Daifuku - Mercer Island WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Dina Sologub - Kirkland WA, US
Kevin Harris - Bothell WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Dina Sologub - Kirkland WA, US
Kevin Harris - Bothell WA, US
Assignee:
Koronis Pharmaceuticals, Incorporated - Redmond WA
International Classification:
C07D 251/08, C07D 251/10, A61K 31/53, A61P 31/18
US Classification:
544196, 544197, 544198, 544204, 544205, 544206, 544220, 544221, 514241, 514245
Abstract:
The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
Mutagenic Heterocycles
US Patent:
2008000, Jan 10, 2008
Filed:
Dec 27, 2006
Appl. No.:
11/616713
Inventors:
Richard Daifuku - Mercer Island WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Assignee:
Koronis Pharmaceuticals, Inc. - Redmond WA
International Classification:
A61K 31/341, A61K 31/4196, A61K 31/53, A61P 31/18, C07D 249/12, C07D 307/04, C07D 403/02, C07D 403/14, C07D 487/02, C07D 487/12
US Classification:
514243000, 514245000, 514262100, 514267000, 514384000, 514461000, 544184000, 544198000, 544251000, 544257000, 548263200, 549429000
Abstract:
The present invention provides compounds as well as methods of using the compounds as antiviral and anti-cancer chemotherapeutic agents.
Mutagenic Nucleoside Analogs For The Treatment Of Viral Disease
US Patent:
2003017, Sep 11, 2003
Filed:
Aug 21, 2002
Appl. No.:
10/226799
Inventors:
Ling Li - Seattle WA, US
Alexander Gall - Woodinville WA, US
Richard Daifuku - Mercer Island WA, US
Alexander Gall - Woodinville WA, US
Richard Daifuku - Mercer Island WA, US
Assignee:
Koronis Pharmaceuticals, Inc. - Redmond WA
International Classification:
A61K031/7072, C12N007/00
US Classification:
435/235100, 514/049000
Abstract:
The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs.
Prodrugs Of Heteroaryl Compounds
US Patent:
2005001, Jan 20, 2005
Filed:
Mar 31, 2004
Appl. No.:
10/816161
Inventors:
Richard Daifuku - Mercer Island WA, US
Alexande Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Dina Sologub - Kirkland WA, US
Kevin Harris - Bothell WA, US
Alexande Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Dina Sologub - Kirkland WA, US
Kevin Harris - Bothell WA, US
Assignee:
Koronis Pharmaceuticals, Incorporated - Redmond WA
International Classification:
A61K031/53, C07D251/48, C 07D 4 3/02
US Classification:
514241000, 544208000, 544209000
Abstract:
The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
Mutagenic Heterocycles
US Patent:
2008003, Feb 7, 2008
Filed:
Dec 10, 2004
Appl. No.:
11/579751
Inventors:
Richard Daifuku - Mercer Island WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Assignee:
Koronis Pharmaceuticals, Incorporated - Redmond WA
International Classification:
C07D 239/00, C07D 249/12, C07D 307/02, C07D 403/00, C07D 475/04, C07D 487/00
US Classification:
544184000, 544209000, 544251000, 544254000, 544261000, 548263200, 549476000
Abstract:
The present invention provides compounds as well as methods of using the compounds as antiviral and anti-cancer chemotherapeutic agents.
Mutagenic Nucleoside Analogs For The Treatment Of Viral Disease
US Patent:
2010027, Nov 4, 2010
Filed:
Dec 27, 2006
Appl. No.:
11/616622
Inventors:
Ling Li - Seattle WA, US
Alexander Gall - Woodinville WA, US
Richard Daifuku - Mercer Island WA, US
Alexander Gall - Woodinville WA, US
Richard Daifuku - Mercer Island WA, US
Assignee:
Koronis Pharmaceuticals, Inc. - Redmond WA
International Classification:
A61K 31/708, C12N 7/06, A61K 31/7072, A61P 31/16, A61P 31/14, A61P 31/20, C07H 19/06, C07H 19/16, A61P 31/18
US Classification:
514 45, 435238, 514 50, 536 2853, 536 277
Abstract:
The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs.
Prodrugs Of Heteroaryl Compounds
US Patent:
7589092, Sep 15, 2009
Filed:
Dec 27, 2006
Appl. No.:
11/616646
Inventors:
Richard Daifuku - Mercer Island WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Dina Sologub - Kirkland WA, US
Kevin Harris - Bothell WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Dina Sologub - Kirkland WA, US
Kevin Harris - Bothell WA, US
Assignee:
Koronis Pharmaceuticals, Incorporated - Redmond WA
International Classification:
A61K 31/53, A61K 31/18, C07D 251/08, C07D 251/10, C07D 405/04
US Classification:
514241, 514245, 544196, 544197, 544198, 544204, 544205, 544206, 544220, 544221
Abstract:
The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
Prodrugs Of Heteroaryl Compounds
US Patent:
8324379, Dec 4, 2012
Filed:
May 16, 2011
Appl. No.:
13/108956
Inventors:
Richard Daifuku - Mercer Island WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Dina Sologub - Kirkland WA, US
Kevin Harris - Bothell WA, US
Alexander Gall - Woodinville WA, US
Dmitri Sergueev - Bothell WA, US
Dina Sologub - Kirkland WA, US
Kevin Harris - Bothell WA, US
Assignee:
Koronis Pharmaceuticals, Inc. - Redmond WA
International Classification:
C07D 251/08, C07D 251/10, A61K 31/53, A61P 31/18
US Classification:
544196, 544197, 544198, 544204, 544205, 544206, 544220, 544221, 514241, 514245
Abstract:
The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.